Reference drugs for triple combination test drug in Russia [Design Issues]

posted by Yura – Belarus, 2019-11-19 21:51 (1040 d 02:48 ago) – Posting: # 20830
Views: 4,282

(edited by mittyri on 2019-11-19 22:50)

Hi Beholder,
There is no reason for the regulator not to want to check section 4.5 of the Guideline on clinical development of fixed combination medicinal products :|>
Kind regards,

Edit: Guideline linked. Also changed the name in signature to the usual one[Mittyri]

Complete thread:

UA Flag
 Admin contact
22,385 posts in 4,684 threads, 1,594 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 01:40 CEST (Europe/Vienna)

You really don’t know what you don’t know until you write about it.
Then, everyone knows what you don’t know.    Rod Machado

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz